Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

6G9M

Fragment-based discovery of a highly potent, orally bioavailable inhibitor which modulates the phosphorylation and catalytic activity of ERK1/2

Experimental procedure
Experimental methodSINGLE WAVELENGTH
Source typeROTATING ANODE
Source detailsRIGAKU FR-X
Temperature [K]100
Detector technologyPIXEL
Collection date2015-04-16
DetectorDECTRIS PILATUS 300K
Wavelength(s)1.54178
Spacegroup nameP 1 21 1
Unit cell lengths48.808, 70.843, 60.375
Unit cell angles90.00, 109.65, 90.00
Refinement procedure
Resolution28.920 - 1.860
R-factor0.16
Rwork0.157
R-free0.20600
Structure solution methodFOURIER SYNTHESIS
RMSD bond length0.013
RMSD bond angle1.080
Data reduction softwareXDS
Data scaling softwareAimless
Phasing softwareBUSTER
Refinement softwareBUSTER (2.11.7)
Data quality characteristics
 OverallOuter shell
Low resolution limit [Å]30.0601.870
High resolution limit [Å]1.8601.860
Rmeas0.0490.794
Number of reflections31764436
<I/σ(I)>15.11.3
Completeness [%]97.389.7
Redundancy2.8
Crystallization Conditions
crystal IDmethodpHtemperaturedetails
1VAPOR DIFFUSION, SITTING DROP7.22932M (NH4)2SO4 32% MPEG 2000 .02M Mercaptoethanol .1M pH=7.2 HEPES/NaOH

225946

PDB entries from 2024-10-09

PDB statisticsPDBj update infoContact PDBjnumon